To develop an acetylshikonin/galunisertib dual-drug core–shell Gel/PCL nanofibrous membrane for radiation-induced skin injury.
ZiMan Li
Radiopharmaceuticals, Theranostics, and Nuclear Medicine
Institution profile
Changzhou Second People's Hospital
Rank #644 · 1 unique linked submissions.
People